Arkolith/Insider Trading/DICE/Form 4

Scopa James Paul

DirectorDICE Therapeutics, Inc. (DICE) · full profile →Form 4 · filed Mar 21, 2023
Net Selling
Open-Market Buys
$0
Open-Market Sells
$291K
Net Open-Market Flow
-$291K
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 17, 2023Sell(S)10K$29.05$291K24K
Oct 24, 2022Gift(G)31K—$034K
Oct 24, 2022Gift(G)31K—$022K

Transaction Codes

S
Open-market sale
G
Gift

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-23-020299) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML